AU6164098A - Novel human mago nashi protein - Google Patents

Novel human mago nashi protein

Info

Publication number
AU6164098A
AU6164098A AU61640/98A AU6164098A AU6164098A AU 6164098 A AU6164098 A AU 6164098A AU 61640/98 A AU61640/98 A AU 61640/98A AU 6164098 A AU6164098 A AU 6164098A AU 6164098 A AU6164098 A AU 6164098A
Authority
AU
Australia
Prior art keywords
novel human
mago nashi
nashi protein
protein
human mago
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU61640/98A
Inventor
Surya K. Goli
Jennifer L. Hillman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Pharmaceuticals Inc filed Critical Incyte Pharmaceuticals Inc
Publication of AU6164098A publication Critical patent/AU6164098A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU61640/98A 1997-02-14 1998-02-12 Novel human mago nashi protein Abandoned AU6164098A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80174197A 1997-02-14 1997-02-14
US08801741 1997-02-14
PCT/US1998/002814 WO1998036069A1 (en) 1997-02-14 1998-02-12 Novel human mago nashi protein

Publications (1)

Publication Number Publication Date
AU6164098A true AU6164098A (en) 1998-09-08

Family

ID=25181927

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61640/98A Abandoned AU6164098A (en) 1997-02-14 1998-02-12 Novel human mago nashi protein

Country Status (5)

Country Link
EP (1) EP0979275A1 (en)
JP (1) JP2001514489A (en)
AU (1) AU6164098A (en)
CA (1) CA2280896A1 (en)
WO (1) WO1998036069A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5168193A (en) * 1992-09-30 1994-04-26 Medical Research Council Human homologs of the transducin-like enhancer of split gene and methods based thereon
CA2201887C (en) * 1994-10-07 2009-04-14 Matthew P. Scott Patched genes and their use
US5807708A (en) * 1996-07-30 1998-09-15 Millennium Pharmaceuticals, Inc. Conservin nucleic acid molecules and compositions

Also Published As

Publication number Publication date
WO1998036069A1 (en) 1998-08-20
JP2001514489A (en) 2001-09-11
EP0979275A1 (en) 2000-02-16
CA2280896A1 (en) 1998-08-20

Similar Documents

Publication Publication Date Title
AU6030398A (en) Human proteins
AU5721798A (en) Human mage-like protein
AU8160898A (en) Human extracellular matrix proteins
AU3902297A (en) Two human nsp-like proteins
AU2095299A (en) Human signal peptide-containing proteins
AU4750097A (en) Human reg i-gamma protein
AU6579898A (en) Human pancreatitis-associated protein, pap-2
AU2205499A (en) Human regulatory proteins
AU4480697A (en) Human nm23-like protein
AU7714398A (en) Two new human dnaj-like proteins
AU5517498A (en) Novel human gtp-binding proteins
AU9017598A (en) Human frezzled-like protein
AU7954298A (en) Human protein phosphatase ii-c-like protein
AU6056898A (en) Human lea-motif developmental protein
AU7410598A (en) Novel human RNA binding protein
AU7148798A (en) New human retinoid binding protein
AU5707498A (en) Novel human membrane protein
AU8665898A (en) Human longevity-assurance protein homologs
AU5621798A (en) Human pathogenesis-related protein
AU7368898A (en) Human translocation associated protein
AU6035298A (en) Human zinc binding proteins
AU7135398A (en) Human rho protein
AU6275098A (en) Novel h-rev 107-like protein
AU4744997A (en) Novel human phospholemman-like protein
AU5827498A (en) Human membrane protein